A GeneSight® Psychotropic Case Study
Background
Behavioral health drug selection and dosing is a trial and error process that often leads to delayed response time, frustration and increased medical costs. There is a high degree of variability in response to behavioral health medications, some of which is due to individual genetics. Assurex Health utilizes its GeneSight proprietary CPGx® combinatorial pharmacogenomics technology to understand how unique inherited traits might influence a patient’s response to medication. GeneSight Psychotropic is a pharmacogenomic test developed to help healthcare providers select medications commonly prescribed to treat behavioral health conditions. There have been multiple studies published in peer reviewed journals addressing the clinical utility of GeneSight Psychotropic.1–4